COMMUNIQUÉS West-GlobeNewswire

Legend Senior Living® Expands Pennsylvania Footprint with Three Hemsley House Communities in Malvern, Dresher, and North Wales
02/06/2026
WICHITA, Kan., June 02, 2026 (GLOBE NEWSWIRE) -- Legend Senior Living, a national senior housing provider headquartered in Wichita, Kansas, has announced it will assume management of three communities, further expanding [...]
Adverse Effects of COVID Vaccine on Musculoskeletal Conditions Need Research, according to the Journal of American Physicians and Surgeons
02/06/2026
TUCSON, Ariz., June 02, 2026 (GLOBE NEWSWIRE) -- The contentious issue of musculoskeletal adverse effects of COVID-19 vaccines arises in the context of the collapse of public trust in academic expertise, writes Jane M. [...]
Update on the Carbios - Wankai project in China
02/06/2026
Clermont-Ferrand (France), 2 June 2026 (05:45 pm CEST). Carbios (Euronext Growth Paris: ALCRB) provides an update on the progress of its strategic partnership with Wankai New Materials (“ Wankai ”) in the field of PET [...]
Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference
02/06/2026
Press release – No. 12 / 2026 Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference Copenhagen, Denmark, June 2, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology [...]
Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules
02/06/2026
$8.5 million upfront with up to approximately $15.1 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond [...]
Physicians Subjected to Unreliable ‘Lie-Detector’ Tests, according to the Journal of American Physicians and Surgeons
02/06/2026
TUCSON, Ariz., June 02, 2026 (GLOBE NEWSWIRE) -- Although polygraphs (“lie-detector” tests) are considered too unreliable to be admissible in federal and most state courts, physicians are often being forced to submit to [...]
AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share
02/06/2026
PRESS RELEASE STONEGATE CAPITAL PARTNERS UPDATES ITS COVERAGE OF AB SCIENCE’S STOCK WITH A DISCOUNTED CASH FLOW VALUATION MID-POINT OF EUR 4.25 PER SHARE Paris, June 2 nd , 2026, 6pm CET AB Science SA (Euronext - [...]
GENFIT Annual General Meeting of June 15, 2026 - Shareholders' letter
02/06/2026
Dear Shareholders, We are pleased to send you, in the attached document, GENFIT’s Shareholders’ Letter published ahead of our Annual General Meeting to be held on June 15, 2026. This letter outlines the key elements [...]
AB Science : Stonegate Capital Partners actualise sa couverture de l'action AB Science avec un objectif de cours de 4,25 EUR par action
02/06/2026
COMMUNIQUÉ DE PRESSE STONEGATE CAPITAL PARTNERS ACTUALISE SA COUVERTURE DE L'ACTION AB SCIENCE AVEC UN OBJECTIF DE COURS DE 4,25 EUR PAR ACTION EN VALEUR MÉDIANE, SUR LA BASE DES FLUX DE TRÉSORERIE ACTUALISÉS Paris, 2 [...]
FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
02/06/2026
Guidance shows how sponsors can build on existing science, reducing redundant testing and accelerating treatments for patients with rare and life-threatening diseases Silver Spring, MD, June 02, 2026 (GLOBE NEWSWIRE [...]
Point d’avancement sur le projet Carbios - Wankai en Chine
02/06/2026
Clermont-Ferrand (France), 2 juin 2026 (17h45 CEST). Carbios (Euronext Growth Paris : ALCRB) fait le point sur l’avancement de son partenariat stratégique avec Wankai New Materials (« Wankai ») dans le domaine du [...]
GENFIT : Assemblée Générale Mixte du 15 juin 2026 - Lettre aux actionnaires
02/06/2026
Chers Actionnaires, Nous avons le plaisir de vous adresser, en pièce jointe, la Lettre aux actionnaires de GENFIT publiée à l’approche de notre Assemblée Générale Mixte du 15 juin 2026. Cette lettre revient sur les [...]
Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System
02/06/2026
A leading academic center becomes the first user in the Southeast, Mid-Atlantic region HINGHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative [...]
Bay Area Lyme Ventures Invests in Galaxy Diagnostics to Advance Tick-Borne Disease Testing
02/06/2026
Partnership Aims to Accelerate Innovation in Diagnostic Tools for Patients with Complex Tick and Vector-Borne Illnesses DURHAM, NC., June 02, 2026 (GLOBE NEWSWIRE) -- Galaxy Diagnostics , a leader in advanced vector- [...]
ASHA: This Summer, Protect Your Hearing Without Missing the Fun
02/06/2026
From Fireworks to Sports and Concerts, Simple Steps Can Help Protect Your Hearing Rockville, MD, June 02, 2026 (GLOBE NEWSWIRE) -- With a summer packed full of events and activities—World Cup matches, July 4th and [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Advancing Proprietary Solutions Focused on Nanotechnology-Enabled Drug Delivery, AI-Enhanced Biomedical Infrastructure
02/06/2026
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic [...]
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
02/06/2026
Bunkerhill Health’s FDA-cleared ECG-EF algorithm for the detection of reduced ejection fraction becomes the first cleared AI-ECG algorithm available through MyoVista Insights, advancing HeartSciences’ SaaS-based, [...]
Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
02/06/2026
Daix (France), New York City (New York, United States), le 2 juin 2026 – Inventiva (Euronext Paris et NASDAQ: IVA ) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement d’une [...]
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors
02/06/2026
Appointments Add Deep Biopharmaceutical Commercial Strategy, Clinical and Finance Expertise as Company Advances Toward Potential Cytisinicline Approval and Launch SEATTLE and VANCOUVER, British Columbia, June 02, 2026 ( [...]

Pages